There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Galactose-deficient IgA1 (Gd-IgA1) plays a crucial role in the development of IgA
nephropathy (IgAN). However, the pathogenic mechanisms driving Gd-IgA1 production
have not been fully elucidated. Innate-immune activation via Toll-like receptor
9 (TLR9) is known to be involved in Gd-IgA1 production. A proliferation-inducing ligand
(APRIL) and IL-6 are also known to enhance Gd-IgA1 synthesis in IgAN. Here, we investigated
how TLR9 activation in IgA-secreting cells results in overproduction of nephritogenic
IgA in the IgAN-prone ddY mouse model and in human IgA1-secreting cells. Injection
of CpG-ODN (TLR9 ligand) increased production of aberrantly glycosylated IgA and IgG-IgA
immune complexes (IC) in ddY mice that, in turn, exacerbated kidney injury. CpG-ODN-stimulated
mice had elevated serum levels of APRIL that correlated with those of aberrantly glycosylated
IgA and IgG-IgA IC. In vitro , TLR9 activation enhanced production of the nephritogenic
IgA as well as APRIL and IL-6 in splenocytes of ddY mice and in human IgA1-secreting
cells. However, siRNA knock-down of APRIL completely suppressed overproduction of
Gd-IgA1 induced by IL-6. Neutralization of IL-6 reduced CpG-ODN-induced overproduction
of Gd-IgA1. Furthermore, APRIL and IL-6 pathways each independently mediated TLR9-induced
overproduction of Gd-IgA1. In summary, TLR9 activation enhanced synthesis of aberrantly
glycosylated IgA that, in a mouse model of IgAN, further enhanced kidney injury. These
findings indicate that APRIL and IL-6 synergistically, as well as independently, enhance
synthesis of Gd-IgA1.